Glox Therapeutics
- Business Model
- B2B
- Website
- gloxtherapeutics.com
- Total Funding
- $5.2M
- Last Round
- $5.2M GrantNov 2024
- Rounds
- 2
About
Anti-Infectives (AMR)
Summary
Glox Therapeutics is a Biotech company. It has raised $5.2M in total across 2 rounds, most recently a $5.2M Grant round in Nov 2024. Investors include Pace Ventures, Boehringer Ingelheim Venture Fund and Scottish Enterprise.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2024
Sign up to see all 2 events
Funding: Seed through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/glox-therapeutics"><img src="https://indexed.vc/api/badge/company/glox-therapeutics" alt="Glox Therapeutics on Indexed.vc" width="260" height="76" /></a>